XKRX000070
Market cap347mUSD
Dec 27, Last price
65,800.00KRW
1D
0.29%
1Q
-14.91%
Jan 2017
-42.68%
Name
Samyang Holdings Corp
Chart & Performance
Profile
Samyang Holdings Corporation, together its subsidiaries, engages in chemical, food, packaging, pharmaceutical, and other businesses in South Korea. It produces and sells value-added materials, terephthalic acid, polycarbonate (PC) resins, bisphenol-A, engineering plastics, PC and polybutylene terephtalate compounds, PET bottles, and long fiber reinforced thermoplastics. It offers health and wellness products, and starch sugar; and operates a salad & brunch concept restaurant under the Seven Springs name, as well as a bakery under the Café Seven Springs name. In addition, the company develops and sells anti-cancer drugs, such as Genexol and Nanoxel PM; NicoStop, a smoking cessation patch; and biodegradable sutures, including Trisorb and Monosorb, as well as exports its products to 80 countries. Further, it provides IT services comprising IT consulting on system management and integration, and e-business services, as well as solutions in ERP, e-HR, MES, and mobile services to the public, finance, and manufacturing sectors. Samyang Holdings Corporation was founded in 1924 and is based in Seoul, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 3,210,853,492 -3.19% | 3,316,777,826 6.74% | 3,107,313,357 25.74% | |||||||
Cost of revenue | 2,938,363,764 | 3,014,435,999 | 2,617,248,582 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 272,489,727 | 302,341,827 | 490,064,775 | |||||||
NOPBT Margin | 8.49% | 9.12% | 15.77% | |||||||
Operating Taxes | 39,518,690 | 20,814,211 | 70,785,027 | |||||||
Tax Rate | 14.50% | 6.88% | 14.44% | |||||||
NOPAT | 232,971,038 | 281,527,616 | 419,279,748 | |||||||
Net income | 172,365,842 62.84% | 105,849,359 -55.47% | 237,700,631 65.92% | |||||||
Dividends | (37,784,492) | (33,682,243) | (17,429,114) | |||||||
Dividend yield | 7.08% | 6.33% | 2.29% | |||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 845,354,331 | 356,764,504 | 522,239,712 | |||||||
Long-term debt | 814,828,099 | 1,054,110,881 | 802,711,081 | |||||||
Deferred revenue | 380,000 | 476,000 | 248,000 | |||||||
Other long-term liabilities | 20,031,894 | 78,041,338 | 91,017,162 | |||||||
Net debt | (57,389,606) | 489,279,024 | 437,764,262 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 305,813,890 | 95,653,804 | 241,427,670 | |||||||
CAPEX | (151,631,947) | (147,982,558) | (201,639,792) | |||||||
Cash from investing activities | (462,812,857) | (123,729,616) | (254,406,605) | |||||||
Cash from financing activities | 172,079,189 | 85,468,446 | 141,048 | |||||||
FCF | 221,162,851 | 135,137,648 | 100,623,451 | |||||||
Balance | ||||||||||
Cash | 959,002,932 | 784,586,992 | 752,195,863 | |||||||
Long term investments | 758,569,105 | 137,009,369 | 134,990,668 | |||||||
Excess cash | 1,557,029,362 | 755,757,469 | 731,820,863 | |||||||
Stockholders' equity | 2,342,979,794 | 2,202,795,149 | 2,100,554,726 | |||||||
Invested Capital | 2,885,765,279 | 3,215,368,265 | 3,037,834,656 | |||||||
ROIC | 7.64% | 9.00% | 14.70% | |||||||
ROCE | 5.90% | 7.32% | 12.46% | |||||||
EV | ||||||||||
Common stock shares outstanding | 7,740 | 7,740 | 7,740 | |||||||
Price | 69,000.00 0.44% | 68,700.00 -30.04% | 98,200.00 31.81% | |||||||
Market cap | 534,026,742 0.44% | 531,704,887 -30.04% | 760,020,668 31.81% | |||||||
EV | 2,545,338,406 | 1,754,084,589 | 1,873,149,819 | |||||||
EBITDA | 385,887,727 | 416,373,827 | 582,328,775 | |||||||
EV/EBITDA | 6.60 | 4.21 | 3.22 | |||||||
Interest | 47,397,929 | 33,768,000 | 26,606,000 | |||||||
Interest/NOPBT | 17.39% | 11.17% | 5.43% |